Missing out on effective care in idiopathic pulmonary fibrosis: Racial inequality in access to anti-fibrotic therapy

被引:0
|
作者
Pascoe, Amy [1 ]
Smallwood, Natasha [1 ,2 ]
机构
[1] Monash Univ, Cent Clin Sch, Resp Res, Alfred, Vic, Australia
[2] Alfred Hosp, Dept Resp & Sleep Med, Prahran, Vic, Australia
关键词
antifibrotic agents; health disparities; health inequities; idiopathic pulmonary fibrosis; interstitial lung disease; mortality; social determinants of health; DISPARITIES; COPD;
D O I
10.1111/resp.14594
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
See related article
引用
收藏
页码:978 / 979
页数:2
相关论文
共 35 条
  • [1] Anti-fibrotic therapy and lung transplant outcomes in patients with idiopathic pulmonary fibrosis
    Astor, Todd L. L.
    Goldberg, Hilary J. J.
    Snyder, Laurie D. D.
    Courtwright, Andrew
    Hachem, Ramsey
    Pena, Tahuanty
    Zaffiri, Lorenzo
    Criner, Gerard J. J.
    Budev, Marie M. M.
    Thaniyavarn, Tany
    Leonard, Thomas B. B.
    Bender, Shaun
    Barakat, Aliaa
    Breeze, Janis L. L.
    LaCamera, Peter
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2023, 17
  • [2] Outcome of lung transplantation in idiopathic pulmonary fibrosis with previous anti-fibrotic therapy
    Leuschner, Gabriela
    Stocker, Florian
    Veit, Tobias
    Kneidinger, Nikolaus
    Winter, Hauke
    Schramm, Rene
    Weig, Thomas
    Matthes, Sandhya
    Ceelen, Felix
    Arnold, Paola
    Munker, Dieter
    Klenner, Friederike
    Hatz, Rudolf
    Frankenberger, Marion
    Behr, Juergen
    Neurohr, Claus
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (02) : 268 - 274
  • [3] Prognosis of idiopathic pulmonary fibrosis without anti-fibrotic therapy: a systematic review
    Khor, Yet H.
    Ng, Yvonne
    Barnes, Hayley
    Goh, Nicole S. L.
    McDonald, Christine F.
    Holland, Anne E.
    EUROPEAN RESPIRATORY REVIEW, 2020, 29 (157) : 1 - 16
  • [4] Concomitant corticosteroid with anti-fibrotic therapy for idiopathic pulmonary fibrosis: a prospective multicenter study
    Kato, Motoyasu
    Miyamoto, Atsushi
    Izumi, Shinyu
    Inomata, Minoru
    Kamio, Koichiro
    Sumikawa, Hiromitsu
    Egashira, Ryoko
    Sugiura, Hiroaki
    Araya, Jun
    Takeuchi, Masahiro
    Takahashi, Kazuhisa
    Azuma, Arata
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [5] Anti-fibrotic role of inhaled interferon-γ in idiopathic pulmonary fibrosis
    Hasaneen, Nadia
    Tuong Vu
    Fusiak, Timothy
    Foda, Hussein
    Condos, Rany
    Smaldone, Gerald
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [6] Newer developments in idiopathic pulmonary fibrosis in the era of anti-fibrotic medications
    Nair, Girish B.
    Matela, Ajsza
    Kurbanov, Daniel
    Raghu, Ganesh
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2016, 10 (06) : 699 - 711
  • [7] Real-life survival of idiopathic pulmonary fibrosis with anti-fibrotic medication
    Bleinc, Alexandre
    Blin, Timothee
    Legue, Sylvie
    Mankikian, Julie
    Plantier, Laurent
    Marchand-Adam, Sylvain
    REVUE DES MALADIES RESPIRATOIRES, 2023, 40 (05) : 371 - 381
  • [8] Clinico-radiological features and efficacy of anti-fibrotic agents in atypical idiopathic pulmonary fibrosis
    Sugino, Keishi
    Shimizu, Hiroshige
    Nakamura, Yasuhiko
    Isshiki, Takuma
    Matsumoto, Keiko
    Homma, Sakae
    JOURNAL OF THORACIC DISEASE, 2018, 10 (02) : 899 - 908
  • [9] Anti-fibrotic effects of pirfenidone in lung fibroblasts derived from patients with idiopathic pulmonary fibrosis
    Hostettler, Katrin
    Papakonstantinou, Eleni
    Klagas, Ioannis
    Bonovolias, Ioannis
    Sun, Qingzhu
    Tamm, Michael
    Lambers, Christopher
    Roth, Michael
    EUROPEAN RESPIRATORY JOURNAL, 2015, 46
  • [10] Effects of Anti-Fibrotic Drugs on Transcriptome of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis
    Ishii, Daisuke
    Kawasaki, Takeshi
    Sato, Hironori
    Tatsumi, Koichiro
    Imamoto, Takuro
    Yoshioka, Keiichiro
    Abe, Mitsuhiro
    Hasegawa, Yoshinori
    Ohara, Osamu
    Suzuki, Takuji
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (07)